Skip to main content
v2026.11,986 entries · CC-BY 4.0

CIN Agar: Principle, Formula, and Lab Guide

Guide to CIN agar: selective formulation, bull’s-eye colony morphology, and biochemical protocols for recovering Yersinia enterocolitica in the laboratory.

Written and maintained by CASRAI Editorial Board

Published

On this page

CIN agar (cefsulodin-irgasan-novobiocin agar) is a selective and differential solid culture medium designed specifically for the isolation and enumeration of Yersinia enterocolitica from clinical stool specimens, food products, and environmental water samples. Developed by D. A. Schiemann in 1979, the formulation incorporates three selective antimicrobial agents—cefsulodin, irgasan (triclosan), and novobiocin—combined with sodium desoxycholate and crystal violet to suppress competing Gram-negative enteric bacilli, pseudomonads, and Gram-positive background flora. Differentiation is mediated by D-mannitol fermentation detected by neutral red: Yersinia enterocolitica colonies absorb the indicator upon localized acidification, developing a pathognomonic “bull’s-eye” morphology featuring a deep red center surrounded by a transparent, colorless outer halo.

Definition, Chemical Formulation, and Selective Principle

CIN agar is recognized in regulatory compendia, including Chapter 8 of the FDA Bacteriological Analytical Manual (BAM Media M35) and ISO 10273, as the primary solid isolation medium for pathogenic Yersinia. In routine clinical stool examinations, Yersinia enterocolitica is easily overlooked on standard enteric formulations like MacConkey agar or Salmonella-Shigella (SS) agar, where it forms non-distinctive lactose-negative colonies that are rapidly overgrown by normal coliforms. Schiemann formulated CIN agar to provide selective suppression of competing microflora while supporting high quantitative recovery of Yersinia.

Per FDA BAM Media M35, the formulation per liter of purified water consists of:

  • Special Peptone (20.0 g): Supplies amino acids, peptides, and organic nitrogen. Unlike chemically defined media that rely on discrete inorganic salts and single amino acids, these enzymatic digests supply complex nutrients essential for robust growth of fastidious enteric bacilli.
  • Yeast Extract (2.0 g): Provides B-complex vitamins, nucleotide precursors, and trace cofactors.
  • D-Mannitol (20.0 g): The primary differential carbohydrate, fermented by Y. enterocolitica to yield acidic end-products.
  • Sodium Pyruvate (2.0 g): Stimulates bacterial resuscitation and protects oxygen-sensitive enzymes by scavenging toxic peroxides.
  • Sodium Chloride (1.0 g): Maintains osmotic equilibrium across the agar matrix.
  • Magnesium Sulfate Heptahydrate (10.0 mg): Supplies divalent cations essential for enzymatic reactions and cell envelope stability.
  • Sodium Desoxycholate (0.5 g): A bile acid salt that selectively inhibits non-enteric bacteria and Gram-positive species.
  • Neutral Red (30.0 mg): pH indicator shifting from orange at pH 7.4 to deep red under localized acidic conditions (pH ≤ 6.8).
  • Crystal Violet (1.0 mg): Suppresses Gram-positive cocci, particularly enterococci and staphylococci.
  • Cefsulodin (15.0 mg): A third-generation cephalosporin with targeted bactericidal activity against Pseudomonas aeruginosa and other non-fermentative Gram-negative rods.
  • Irgasan (Triclosan) (4.0 mg): A chlorinated bisphenol that blocks bacterial fatty acid biosynthesis via FabI inhibition, suppressing Gram-positive organisms and enteric coliforms.
  • Novobiocin (2.5 mg): An aminocoumarin antibiotic targeting DNA gyrase subunit B in Gram-positive bacteria.
  • Strontium Chloride (1.0 g): Enhances selective inhibition and clarifies the colonial precipitation boundary in BAM M35 recipes.
  • Agar (12.0 g to 13.5 g): Solidifying agent; the final pH is adjusted to 7.4 ± 0.2 at 25°C.

The coordinated synergy between cefsulodin, irgasan, and novobiocin is what gives CIN agar its exceptional selectivity. Pseudomonads are inhibited by cefsulodin, enterobacteria by irgasan, and Gram-positive flora by novobiocin and crystal violet, creating a selective window that permits isolated growth of Yersinia even from heavily contaminated specimens.

Colony Morphology and the Bull’s-Eye Diagnostic Reaction

The distinctive colonial appearance of Yersinia enterocolitica on CIN agar is described as a “bull’s-eye.” This morphology is driven by the localized kinetics of mannitol fermentation and dye absorption within the developing colony. As Y. enterocolitica divides, it ferments the surrounding D-mannitol into lactic and acetic acids, driving the local pH below 6.8. In this acidic zone, neutral red precipitates and is absorbed into the bacterial biomass at the dense colony center, producing a dark red, ruby, or magenta core. At the outer periphery, metabolic acid is diluted by the surrounding buffered medium, leaving a clear, colorless zone.

  • At 24 Hours (25°C to 30°C): Colonies are small (1.0 to 1.5 mm in diameter) and circular with an entire edge. They display a pinpoint, deep red center surrounded by a narrow, transparent perimeter. In transmitted light, the dark central core appears sharply delineated.
  • At 48 Hours: Colonies expand to 2.0 to 3.5 mm. The central red core deepens, and the outer transparent halo widens. In areas of dense growth, a faint precipitate ring of bile salts may appear around colonies due to desoxycholate insolubility under low pH.

Non-mannitol fermenters that tolerate the antimicrobial agents (such as resistant Pseudomonas mutants) form completely clear, colorless colonies without a red center. Organisms that ferment mannitol rapidly with diffuse acid and gas production produce broad, irregular pink colonies that lack the crisp outer halo characteristic of Yersinia.

Clinical and Food Testing Protocols: Plating, Cold Enrichment, and Alkali Treatment

Isolation protocols for Yersinia enterocolitica depend on sample type and expected bacterial load. In acute human yersiniosis, stool specimens contain high titers (10^5 to 10^7 CFU/g), permitting direct plating on CIN agar. In contrast, food products, raw pork, milk, and water samples typically carry low pathogen levels alongside overwhelming background microflora, requiring cold enrichment and chemical treatment.

When inoculating plates, analysts select between streak plate vs spread plate methods based on the diagnostic objective. Quadrant streak plating using a sterile loop is standard for qualitative isolation from clinical stools and enrichments. Spread plating (pipetting 0.1 mL of suspension across the surface with a sterile spreader) is used for quantitative pathogen enumeration in regulatory food analyses.

  • Cold Enrichment Procedure: Yersinia enterocolitica is psychrotrophic, capable of replication at 0°C to 44°C, with active growth at 4°C. Per FDA BAM Chapter 8, a 25 g food sample is homogenized in 225 mL Peptone Sorbitol Bile Broth (PSBB) and incubated at 10°C for 10 days (or at 4°C for 14 to 21 days in phosphate-buffered saline for clinical samples). Mesophilic competitors enter dormancy or decline, whereas Yersinia multiplies.
  • Alkali Treatment Protocol (0.5% KOH): To eliminate background psychrotrophs surviving cold enrichment, BAM Chapter 8 employs alkali treatment. A 0.1 mL aliquot of enrichment broth is mixed with 0.1 mL of freshly prepared 0.5% KOH in 0.5% NaCl for exactly 2 to 3 seconds, followed by immediate streaking onto CIN agar. Yersinia enterocolitica possesses an alkali-resistant outer membrane that withstands pH 11.5–12.0 for several seconds, whereas competing Gram-negative rods undergo cell lysis. Plating must occur immediately; contact exceeding 10 seconds reduces Yersinia viability.

Laboratory handling of Yersinia enterocolitica requires adherence to Biosafety Level 2 (BSL-2) containment standards. Stool processing and aerosol-generating steps must be conducted within certified biosafety cabinets to protect personnel from accidental ingestion or inhalation.

Differentiating Yersinia from Morphological Look-Alikes

CIN agar is selective, but not fully species-specific. Several non-Yersinia organisms can grow on the medium and ferment mannitol, forming colonies that mimic the classic bull’s-eye appearance. False identification can trigger misdiagnoses or unnecessary food recalls, making confirmatory screening essential before issuing final reports.

The primary organisms that produce look-alike colonies on CIN agar include:

  • Aeromonas hydrophila: Readily forms colonies with deep red centers and clear perimeters. The definitive discriminator is the oxidase test: Aeromonas is strongly oxidase-positive, whereas Yersinia enterocolitica is universally oxidase-negative. An oxidase test performed directly on suspicious colonies provides differentiation in seconds.
  • Citrobacter freundii: Can produce pinkish colonies on CIN agar. C. freundii is distinguished by producing hydrogen sulfide (H2S) and gas in Triple Sugar Iron (TSI) or Kligler Iron Agar (KIA), and exhibiting active motility at both 25°C and 37°C.
  • Enterobacter agglomerans (Pantoea agglomerans): Forms red-centered colonies on CIN agar (Devenish and Schiemann, 1981). Unlike pathogenic Yersinia, Pantoea is urease-negative and hydrolyzes esculin.
  • Serratia marcescens: Can form reddish colonies from mannitol fermentation or prodigiosin pigment. It is urease-negative, hydrolyzes esculin, and is motile at 37°C.
  • Morganella morganii: May produce pale colonies with reddish discoloration, but is phenylalanine deaminase-positive and hydrolyzes urea rapidly within 2 to 4 hours, unlike the slower 24- to 48-hour urease reaction of Yersinia.

The abbreviated screening scheme established by Devenish and Schiemann (1981) and endorsed by the FDA BAM relies on two primary tube media inoculated from suspect bull’s-eye colonies:

  • Lysine Arginine Iron Agar (LAIA) or KIA: Yersinia enterocolitica produces an alkaline slant and acid butt without gas and without H2S (K/A – -). Cultures showing gas production, agar splitting, or blackening (H2S) are discarded.
  • Christensen’s Urea Slant: Inoculated tubes incubated at 25°C turn magenta-pink within 24 to 48 hours, confirming urease activity. Urease-negative colonies are rejected.
  • Temperature-Dependent Motility: Yersinia enterocolitica is motile via peritrichous flagella at 22°C to 25°C, but becomes non-motile at 35°C to 37°C due to transcriptional repression of flagellar genes. Competing enterobacteria remain motile at both temperatures.

Laboratory Quality Control and Media Preparation Guidelines

Reliable performance of CIN agar depends on correct preparation and routine quality control (QC). Cefsulodin and novobiocin are heat-labile and must be added aseptically after the basal agar has been autoclaved and cooled. Laboratories preparing CIN agar should adhere to the following protocol:

  1. Dissolution and Autoclaving: Suspend 58.5 g of dehydrated base powder in 1000 mL of purified water. Laboratories must maintain strict criteria regarding distilled vs sterile water to ensure freedom from chlorine, metal ions, or organic contaminants that could inhibit bacterial resuscitation. Heat with agitation and boil for 1 minute to dissolve. Autoclave at 121°C for 15 minutes.
  2. Tempering: Cool the molten base in a water bath to 45°C to 50°C. Never add selective supplements above 50°C to avoid thermal antibiotic breakdown.
  3. Supplement Addition: Reconstitute selective supplement vials (cefsulodin, irgasan, novobiocin) per manufacturer instructions. Aseptically add the supplement to the tempered base, mixing gently to prevent bubbles. Add filter-sterilized strontium chloride if preparing manual BAM M35.
  4. Pouring and Storage: Dispense 15 to 20 mL into sterile Petri dishes. Once solidified, store inverted in sealed, light-protective bags at 2°C to 8°C. Poured plates should be used within 4 to 8 weeks.

Each production lot must be verified using reference strains before release:

  • Yersinia enterocolitica ATCC 9610 (or ATCC 27729): Positive control. Must yield good growth with characteristic bull’s-eye colonies within 24 to 48 hours at 25°C–30°C.
  • Escherichia coli ATCC 25922: Gram-negative inhibition control. Must exhibit marked or complete inhibition; any growth must be colorless and non-pigmented.
  • Pseudomonas aeruginosa ATCC 27853: Inhibition control. Must show complete inhibition due to cefsulodin and irgasan.
  • Enterococcus faecalis ATCC 29212: Gram-positive inhibition control. Must show complete inhibition due to crystal violet, bile salts, and novobiocin.

Technical Pitfalls, Temperature Control, and Method Limitations

The primary technical pitfall in CIN agar testing is incubating plates at standard 35°C to 37°C rather than 25°C to 30°C (CDC recommends 25°C; FDA BAM specifies 30°C). Operating at higher temperatures compromises laboratory recovery in three key ways:

  • Virulence Plasmid Curing: Pathogenic Y. enterocolitica isolates carry a 70-kb virulence plasmid (pYV) that mediates calcium-dependent growth and outer membrane Yop protein expression. As demonstrated by Bottone (1997), incubation at 37°C promotes plasmid loss, curing pathogenic strains of their virulence determinants in culture.
  • Colony Demarcation Degradation: At 37°C, excessive acid diffusion obscures the boundary between the red center and clear rim, resulting in diffuse pink colonies that lack classic bull’s-eye morphology.
  • Reduced Selectivity: Cefsulodin and irgasan selectivity is optimized at lower incubation temperatures. At 37°C, competing coliforms grow faster and can overcome antibiotic suppression.

Timing of plate evaluation is equally critical. Reading plates before 24 hours can result in false negatives, as pinpoint colonies may not have accumulated sufficient acid to turn red. Conversely, delaying readings beyond 48 hours allows breakthrough colonies of Serratia or Enterobacter to develop and causes confluent acid diffusion across the agar.

The data table below compares the pure culture recovery, fecal background inhibition, and spike detection thresholds of CIN agar against five alternative enteric isolation media based on multi-strain clinical evaluation data compiled from Head et al. (1982) and foundational performance studies. This empirical comparison demonstrates why CIN agar remains the reference standard across clinical and food regulatory frameworks.

Frequently asked questions

What causes the characteristic bull’s-eye appearance on CIN agar?

The bull’s-eye appearance is caused by the fermentation of D-mannitol by Yersinia enterocolitica, which lowers the local pH around the bacterial colony. The acid induces localized precipitation and uptake of the neutral red indicator within the dense central biomass, creating a deep red core. The actively dividing outer perimeter forms a thin zone where acid has not concentrated, leaving a clear, transparent halo.

Why must CIN agar be incubated at 25°C to 30°C rather than standard 37°C?

Incubation at 25°C to 30°C optimizes the enzymatic growth rate of Yersinia relative to competing mesophilic bacteria, preserves the 70-kb pYV virulence plasmid that can be lost at higher temperatures, and produces sharp, unambiguous bull’s-eye colony differentiation.

Can other bacterial species grow and mimic Yersinia on CIN agar?

Yes. Species such as Aeromonas hydrophila, Citrobacter freundii, and Enterobacter agglomerans (Pantoea) can tolerate the antimicrobial agents and ferment mannitol, producing colonies with red centers. Aeromonas is easily distinguished because it is oxidase-positive, whereas Yersinia is oxidase-negative. Urease testing and motility at 25°C versus 37°C resolve other look-alikes.

How does cold enrichment in peptone sorbitol bile broth assist Yersinia recovery?

Cold enrichment takes advantage of the psychrotrophic nature of Yersinia enterocolitica, which can replicate at temperatures as low as 4°C. Incubating food or environmental samples in broth at 10°C for 10 days allows Yersinia to multiply while competing mesophilic microflora remain dormant or decline, increasing the ratio of target pathogen before selective plating.

What is the purpose of the 0.5% KOH treatment before plating onto CIN agar?

Potassium hydroxide treatment exposes the enrichment broth to alkaline shock (pH ~11.5) for exactly 2 to 3 seconds immediately before streaking. Because Yersinia has an unusually alkali-resistant outer membrane, it survives this brief exposure while competing non-Yersinia Gram-negative bacteria undergo rapid cellular lysis, dramatically reducing background plate contamination.

Sources

  • U.S. Food and Drug Administration. Bacteriological Analytical Manual (BAM) Chapter 8: Yersinia enterocolitica. FDA CFSAN, October 2017. https://www.fda.gov/food/laboratory-methods-food/bam-chapter-8-yersinia-enterocolitica (accessed 2026-11-14).
  • U.S. Food and Drug Administration. Bacteriological Analytical Manual (BAM) Media M35: Cefsulodin-Irgasan-Novobiocin (CIN) Agar or Yersinia Selective Agar (YSA). FDA CFSAN. https://www.fda.gov/food/laboratory-methods-food/bam-media-m35-cefsulodin-irgasan-novobiocin-cin-agar-or-yersinia-selective-agar-ysa (accessed 2026-11-14).
  • Schiemann DA. Synthesis of a selective agar medium for Yersinia enterocolitica. Canadian Journal of Microbiology. 1979;25(11):1298-1304. doi:10.1139/m79-205. https://pubmed.ncbi.nlm.nih.gov/540256/ (accessed 2026-11-14).
  • Head CB, Whitty DA, Ratnam S. Comparative study of selective media for recovery of Yersinia enterocolitica. Journal of Clinical Microbiology. 1982;16(4):615-621. doi:10.1128/jcm.16.4.615-621.1982. https://pubmed.ncbi.nlm.nih.gov/7153309/ (accessed 2026-11-14).
  • Devenish JA, Schiemann DA. An abbreviated scheme for identification of Yersinia enterocolitica isolated from food enrichments on CIN (cefsulodin-irgasan-novobiocin) agar. Canadian Journal of Microbiology. 1981;27(9):937-941. doi:10.1139/m81-146. https://pubmed.ncbi.nlm.nih.gov/7306881/ (accessed 2026-11-14).
  • Bottone EJ. Yersinia enterocolitica: the charisma continues. Clinical Microbiology Reviews. 1997;10(2):257-276. doi:10.1128/CMR.10.2.257. https://pubmed.ncbi.nlm.nih.gov/9105754/ (accessed 2026-11-14).
  • International Organization for Standardization. ISO 10273:2017: Microbiology of the food chain — Horizontal method for the detection of pathogenic Yersinia enterocolitica. ISO, Geneva. https://www.iso.org/standard/64585.html (accessed 2026-11-14).

Data: Comparative Performance and Selectivity of Enteric Isolation Media for Yersinia enterocolitica

Empirical evaluation of six solid culture media for recovering Yersinia enterocolitica across 35 clinical strains, comparing pure culture recovery, background fecal flora inhibition, and detection limits from spiked fecal specimens, compiled from peer-reviewed diagnostic evaluations (Head et al., 1982; Schiemann, 1979) and regulatory reference standards (FDA BAM Chapter 8).

Period covered: 1979/2026. Coverage: Global.

Comparative Performance and Selectivity of Enteric Isolation Media for Yersinia enterocolitica
Culture MediumPure Culture Recovery (%)Fecal Flora Inhibition (%)Recovery at 10^2 CFU/g (%)Recovery at 10^1 CFU/g (%)Diagnostic Incubation Time (h)
CIN Agar (Cefsulodin-Irgasan-Novobiocin)859510010024
MacConkey Agar (MAC)7570048
Salmonella-Shigella Agar (SS)485011048
Cellobiose-Arginine-Lysine Agar (CAL)626563040
Pectin Agar7040048
Y Medium1599.914048

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about CIN Agar: Principle, Formula, and Lab Guide

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →